2038.20
2.62%
Asit C Mehta Investment Interrmediates
CAPLIPOINT has transformed itself into a player in generic formulations with a
differentiated geographical presence. The company focuses on the emerging
markets of LATAM and has taken an early-mover advantage in these largely
untapped markets
Caplin Point Laboratories Ltd. is trading above all available SMAs
More from Caplin Point Laboratories Ltd.
Recommended